A detailed history of Morgan Stanley transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 520,646 shares of ALDX stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
520,646
Previous 311,404 67.19%
Holding current value
$2.49 Million
Previous $1.03 Million 172.43%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.19 - $6.32 $667,481 - $1.32 Million
209,242 Added 67.19%
520,646 $2.81 Million
Q2 2024

Oct 17, 2024

SELL
$3.25 - $4.72 $123,961 - $180,030
-38,142 Reduced 10.91%
311,404 $1.03 Million
Q2 2024

Aug 14, 2024

SELL
$3.25 - $4.72 $123,961 - $180,030
-38,142 Reduced 10.91%
311,404 $1.03 Million
Q1 2024

Oct 17, 2024

BUY
$2.77 - $4.22 $105,653 - $160,959
38,142 Added 12.25%
349,546 $1.14 Million
Q1 2024

Aug 16, 2024

SELL
$2.77 - $4.22 $195,345 - $297,602
-70,522 Reduced 16.79%
349,546 $1.14 Million
Q1 2024

May 15, 2024

SELL
$2.77 - $4.22 $195,345 - $297,602
-70,522 Reduced 16.79%
349,546 $1.14 Million
Q4 2023

Aug 16, 2024

BUY
$1.47 - $6.06 $159,736 - $658,503
108,664 Added 34.89%
420,068 $1.47 Million
Q4 2023

Feb 13, 2024

BUY
$1.47 - $6.06 $251,300 - $1.04 Million
170,953 Added 68.62%
420,068 $1.47 Million
Q3 2023

Nov 15, 2023

SELL
$6.11 - $8.16 $439,388 - $586,810
-71,913 Reduced 22.4%
249,115 $1.66 Million
Q2 2023

Aug 14, 2023

SELL
$7.11 - $11.89 $6.11 Million - $10.2 Million
-858,935 Reduced 72.79%
321,028 $2.69 Million
Q1 2023

May 15, 2023

BUY
$5.77 - $9.93 $4.99 Million - $8.59 Million
864,713 Added 274.29%
1,179,963 $11.7 Million
Q4 2022

Feb 14, 2023

BUY
$5.08 - $7.09 $64,043 - $89,383
12,607 Added 4.17%
315,250 $2.19 Million
Q3 2022

Nov 14, 2022

SELL
$3.8 - $7.74 $236,804 - $482,333
-62,317 Reduced 17.08%
302,643 $1.62 Million
Q2 2022

Oct 27, 2022

BUY
$2.43 - $4.85 $28,698 - $57,278
11,810 Added 3.34%
364,960 $1.46 Million
Q2 2022

Aug 15, 2022

BUY
$2.43 - $4.85 $28,698 - $57,278
11,810 Added 3.34%
364,960 $1.46 Million
Q1 2022

Oct 27, 2022

SELL
$3.25 - $5.17 $38,382 - $61,057
-11,810 Reduced 3.24%
353,150 $1.57 Million
Q1 2022

May 13, 2022

BUY
$3.25 - $5.17 $584,824 - $930,320
179,946 Added 103.89%
353,150 $1.57 Million
Q4 2021

Feb 14, 2022

BUY
$3.5 - $9.63 $413,294 - $1.14 Million
118,084 Added 214.23%
173,204 $693,000
Q3 2021

Nov 15, 2021

BUY
$7.94 - $11.31 $437,652 - $623,407
55,120 New
55,120 $483,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.